Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 1/2 2Phase 3 1Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Lymphoid 2Sarcoma 1Other hematologic neoplasm 1

Conditions

Lymphoma 340Lymphoma, Non-Hodgkin 295Precursor Cell Lymphoblastic Leukemia-Lymphoma 249Leukemia, Lymphocytic, Chronic, B-Cell 235Lymphoma, Large B-Cell, Diffuse 217Leukemia 186Lymphoma, Follicular 183Lymphoma, Mantle-Cell 167Recurrence 142Hodgkin Disease 141Lymphoma, B-Cell 139Leukemia, Myeloid, Acute 133Burkitt Lymphoma 120Lymphoma, B-Cell, Marginal Zone 94Multiple Myeloma 86Myelodysplastic Syndromes 83Waldenstrom Macroglobulinemia 62Lymphoma, T-Cell, Peripheral 57Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 52Neoplasms 52Lymphoma, T-Cell, Cutaneous 52Hematologic Neoplasms 49Lymphoma, Large-Cell, Anaplastic 43Lymphoma, T-Cell 41Lymphoma, Large-Cell, Immunoblastic 41Leukemia, Myelogenous, Chronic, BCR-ABL Positive 40Mycosis Fungoides 38Leukemia, B-Cell 34Sezary Syndrome 30Myeloproliferative Disorders 29

Interventions

ARQ531 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Vascular Diseases × Lymphoid × Clear all
NCT03162536 2025-09-08

ARQ 531-101

ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)

Phase 1/2 Active not recruiting
190 enrolled
LymphoidOther hematologic neoplasmPlasma cellSarcoma

Blood Protein Disorders, Cardiovascular Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Lymphoid, Lymphatic Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Waldenstrom Macroglobulinemia, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Recurrence, Vascular Diseases, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms, Hemostatic Disorders, Lymphoma, Mantle-Cell, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating

NCT06644443 2024-10-16

BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple Myeloma

Shenzhen University General Hospital

Phase 1/2 Recruiting
10 enrolled
LymphoidPlasma cell

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Hemostatic Disorders, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡